Neuro-protective role of metformin in patients with acute stroke and type 2 diabetes mellitus via AMPK/mammalian target of rapamycin (mTOR) signaling pathway and oxidative stress
KKLIU 0685/2019 KKLIU 0685/2019
Priority Applications (1) Applications Claiming Priority (1) Publications (2) Family ID=63572971 Family Applications (1) Country Status (1) Families Citing this family (1) Citations (10) 2018 2018-05-25 CN CN201810530808.9A patent/CN108567970B/en active Active
Hensley K, Benaksas EJ, Bolli R, Comp P, Grammas P, Hamdheydari L et al
Most reported timing is post-workout on training days, which lines up the injection with elevated blood glucose and a planned meal both of which reduce hypoglycemia risk
Research pipeline development through companies like Cleara Biotech provides researchers with insights into translational senolytic development while maintaining focus on research applications